Region | Antimicrobial | MIC (mg/L) | %S + %Ia | %R | |
---|---|---|---|---|---|
MIC90 | Range | ||||
Africa/Middle East (n = 471) | Piperacillin-tazobactam | 128 | 0.25–≥256 | 73.5 | 26.5 |
Aztreonam | 32 | 0.06–≥256 | 79.8 | 20.2 | |
Ceftazidime | 64 | 0.12–≥256 | 79.0 | 21.0 | |
Ceftazidime-avibactam | 8 | ≤0.015–≥256 | 91.9 | 8.1 | |
Cefepime | 32 | ≤0.12–≥64 | 76.6 | 23.4 | |
Imipenem | ≥16 | 0.06–≥16 | 66.7 | 33.3 | |
Meropenemb | 16 | 0.015–≥32 | 82.8 | 17.2 | |
Levofloxacin | ≥16 | 0.03–≥16 | 65.2 | 34.8 | |
Colistin | 2 | 0.12–4 | 99.8 | 0.2 | |
Amikacin | 16 | ≤0.25–≥128 | 92.1 | 7.9 | |
Asia/South Pacific (n = 1007) | Piperacillin-tazobactam | 128 | ≤0.12–≥256 | 72.7 | 27.3 |
Aztreonam | 32 | ≤0.015–≥256 | 79.5 | 20.5 | |
Ceftazidime | 64 | 0.06–≥256 | 76.3 | 23.7 | |
Ceftazidime-avibactam | 8 | ≤0.015–≥256 | 93.4 | 6.6 | |
Cefepime | 32 | ≤0.12–≥64 | 79.3 | 20.7 | |
Imipenem | ≥16 | 0.12–≥16 | 80.1 | 19.9 | |
Meropenemb | 8 | 0.008–≥32 | 90.1 | 9.9 | |
Levofloxacin | ≥16 | 0.008–≥16 | 66.7 | 33.3 | |
Colistin | 2 | ≤0.06–≥16 | 99.2 | 0.8 | |
Amikacin | 8 | ≤0.25–≥128 | 95.6 | 4.4 | |
Europe (n = 3049) | Piperacillin-tazobactam | 128 | ≤0.12–≥256 | 69.2 | 30.8 |
Aztreonam | 32 | 0.03–≥256 | 76.5 | 23.5 | |
Ceftazidime | 64 | 0.06–≥256 | 74.0 | 26.0 | |
Ceftazidime-avibactam | 8 | ≤0.015–≥256 | 91.0 | 9.0 | |
Cefepime | 32 | ≤0.12–≥64 | 76.0 | 24.0 | |
Imipenem | ≥16 | ≤0.03–≥16 | 69.3 | 30.7 | |
Meropenemb | 16 | 0.008–≥32 | 83.1 | 16.9 | |
Levofloxacin | ≥16 | 0.015–≥16 | 59.9 | 40.1 | |
Colistin | 1 | ≤0.06–≥16 | 99.7 | 0.3 | |
Amikacin | 32 | ≤0.25–≥128 | 89.8 | 10.2 | |
Latin America (n = 805) | Piperacillin-tazobactam | 128 | 0.25–≥256 | 69.3 | 30.7 |
Aztreonam | 64 | 0.06–≥256 | 75.9 | 24.1 | |
Ceftazidime | 128 | 0.06–≥256 | 71.2 | 28.8 | |
Ceftazidime-avibactam | 32 | 0.03–≥256 | 85.7 | 14.3 | |
Cefepime | 32 | ≤0.12–≥64 | 72.3 | 27.7 | |
Imipenem | ≥16 | 0.12–≥16 | 62.6 | 37.4 | |
Meropenemb | 16 | ≤0.004–≥32 | 76.6 | 23.4 | |
Levofloxacin | ≥16 | 0.015–≥16 | 60.7 | 39.3 | |
Colistin | 1 | ≤0.06–≥16 | 99.5 | 0.5 | |
Amikacin | 64 | ≤0.25–≥128 | 82.4 | 17.6 |